Abstract:Purpose: 123I-Ioflupane SPECT is an effective tool for the diagnosis and progression assessment of Parkinson's disease (PD). Radiomics and deep learning (DL) can be used to track and analyze the underlying image texture and features to predict the Hoehn-Yahr stages (HYS) of PD. In this study, we aim to predict HYS at year 0 and year 4 after the first diagnosis with combined imaging, radiomics and DL-based features using 123I-Ioflupane SPECT images at year 0. Methods: In this study, 161 subjects from the Parkinson's Progressive Marker Initiative database underwent baseline 3T MRI and 123I-Ioflupane SPECT, with HYS assessment at years 0 and 4 after first diagnosis. Conventional imaging features (IF) and radiomic features (RaF) for striatum uptakes were extracted from SPECT images using MRI- and SPECT-based (SPECT-V and SPECT-T) segmentations respectively. A 2D DenseNet was used to predict HYS of PD, and simultaneously generate deep features (DF). The random forest algorithm was applied to develop models based on DF, RaF, IF and combined features to predict HYS (stage 0, 1 and 2) at year 0 and (stage 0, 1 and ≥ 2) at year 4, respectively. Model predictive accuracy and receiver operating characteristic (ROC) analysis were assessed for various prediction models. Results: For the diagnostic accuracy at year 0, DL (0.696) outperformed most models, except DF + IF in SPECT-V (0.704), significantly superior based on paired t-test. For year 4, accuracy of DF + RaF model in MRI-based method is the highest (0.835), significantly better than DF + IF, IF + RaF, RaF and IF models. And DL (0.820) surpassed models in both SPECT-based methods. The area under the ROC curve (AUC) highlighted DF + RaF model (0.854) in MRI-based method at year 0 and DF + RaF model (0.869) in SPECT-T method at year 4, outperforming DL models, respectively. And then, there was no significant differences between SPECT-based and MRI-based segmentation methods except for the imaging feature models. Conclusion: The combination of radiomic and deep features enhances the prediction accuracy of PD HYS compared to only radiomics or DL. This suggests the potential for further advancements in predictive model performance for PD HYS at year 0 and year 4 after first diagnosis using 123I-Ioflupane SPECT images at year 0, thereby facilitating early diagnosis and treatment for PD patients. No significant difference was observed in radiomics results obtained between MRI- and SPECT-based striatum segmentations for radiomic and deep features.

Improved parkinsonism diagnosis using a partial least squares based approach

An Automated Hybrid Approach Via Deep Learning and Radiomics Focused on the Midbrain and Substantia Nigra to Detect Early-Stage Parkinson’s Disease

High Accuracy Classification of Parkinson's Disease through Shape Analysis and Surface Fitting in $^{123}$I-Ioflupane SPECT Imaging

A New Hybrid Method for Differential Diagnosis of Parkinsonism.

Automatic Classification Of Early Parkinson'S Disease With Multi-Modal Mr Imaging

Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease.

Investigating the Role of 99Mtc-Trodat-1 SPECT Imaging in Idiopathic Parkinson's Disease.

Brain Evaluation by Dual PET/CT with [18F] FDOPA and [18F] FDG in Differential Diagnosis of Parkinsonian Syndromes

Use of Magnetic Resonance Imaging and Artificial Intelligence in Studies of Diagnosis of Parkinson’s Disease

Early Diagnosis of Parkinsons Disease by Analyzing Magnetic Resonance Imaging Brain Scans and Patient Characteristics

Radiomics incorporating deep features for predicting Parkinson's disease in 123I-Ioflupane SPECT

A Fully Automatic Framework for Parkinson’s Disease Diagnosis by Multi-Modality Images

Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients

Computer-Aided Classification Framework of Parkinsonian Disorders Using 11C-CFT PET Imaging

Towards the identification of Parkinson's Disease using only T1 MR Images

Computer-Aided Classification Framework of Parkinsonian Disorders Using <SUP>11</SUP>C-CFT PET Imaging

Practical Overview of 123 I-Ioflupane Imaging in Parkinsonian Syndromes

Advances in the Use of Positronic Radiomolecular Imaging Agents in the Diagnosis of Parkinson's Disease

Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms

Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic Uncertainty